Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market, By Product Type (Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes and Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes), By Application, By End User, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
|
Report ID
ANV6130
|
Published Date
September 2026
|
Pages
367
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Messenger Ribonucleic Acid (mRNA) Capping Enzyme market size was valued at US$ 1,063.4 Million in 2025, expanding at a CAGR of 15.1% from 2026 to 2033.
The mRNA capping enzyme is a protein complex that is involved in the addition of a 7-methylguanosine cap to the 5\' end of the newly formed mRNA transcript for the stability of the RNA molecule, RNA export from the nucleus, and the RNA translation process. The structure of the enzyme that acts as a capping enzyme contains three active centers of protein enzymes, which can function either independently or as a part of the RNA polymerase II complex. These active centers include the capping enzyme, which acts as RNA triphosphatase and removes terminal phosphates from the newly synthesized mRNA transcripts; the capping enzyme, which acts as guanylyl transferase and attaches the GMP from GTP to the 5\' diphosphate of the mRNA; and the capping enzyme, which acts as N7 methyl transferase. Thus, mRNA capping enzymes play a pivotal role in ensuring proper mRNA maturation and functional gene expression.
Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Market Dynamics
Increasing Use Of Personalized Medicine To Boost Market Expansion
Increasing adoption of personalized medicine in IVF is driving Messenger Ribonucleic Acid (mRNA) Capping Enzyme market because it helps in profiling the embryos in a particular way using the genetic constitution of the embryos, helps in the selection of embryos, makes the decision-making process with regard to reproduction easier, and also helps in risk identification related to genetic abnormalities. For instance, in February 2026, according to the Brazilian Registry of Clinical Trials (Gov), there is growing use of personalized medicine because these are providing excellent results and outcomes in refractory hematologic malignancies where CAR-T cells are genetically modified T-lymphocytes against the tumor antigen. The country is working towards building its own capacity and expertise in research, clinics, and regulations so that it can provide patients with such advanced personalized treatments in the future.
As per the Brazil Registry of Clinical Trials, there are a total of 18,826 clinical trials, including 9,632 active registrations of clinical trials, 5,192 recruiting clinical trials, 89 ongoing analysis trials, and 6,240 drafted clinical trials. This trend is expected to accelerate personalized embryo selection and strengthen precision in IVF treatment strategies.
Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Segmentation Analysis:
The Global Messenger Ribonucleic Acid (mRNA) Capping Enzyme market is segmented on the basis of Product Type, Application, End User, and Region.
In the Messenger Ribonucleic Acid (mRNA) Capping Enzyme market, recombinant Messenger Ribonucleic Acid (mRNA) capping enzymes hold a prominent share due to the extensive use of recombinant enzymes like Vaccinia Capping Enzyme (VCE) in artificial mRNA studies and commercialization, especially for 5\' mRNA capping purposes. In March 2026, Roche AG introduced its Vaccinia Capping System, which includes recombinant mRNA guanylyltransferase and 2\'O-methyltransferase enzymes. The Vaccinia Capping System provides capping, which is of GMP quality and has no animal origin. This move is anticipated to increase the use of recombinant enzymes in mRNA production.
Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Geographical Insights
North America is among the most affected regions because of being heavily reliant on imported reagents. It may pose some challenges in terms of supply chains and the difficulties in procurement. For instance, in November 2025, according to U.S. Customs and Border Protection (Gov.), all biological materials imported into the USA, including genetic materials, enzymes, proteins, peptides, diagnostic specimens, cultured cells, antibodies, and other research materials, have to meet the requirements of import documentation, labeling, packaging, declaration, and inspection. If the commercial value of biological materials is higher than $2,500, it will require the formal customs entry process (bonding and duties/taxes/fees).
In case the value is lower than $800, an importer can use the Entry Type 86 electronic filing method if Partner Government Agency (PGA) participation is needed. Also, there are seven categories of biological materials provided by the CBP, which include cultured cells/tissues, diagnostic specimens, genetic materials, genetically modified organisms, human/veterinary products, infectious substances, and microorganisms. This regulatory complexity can further strain supply chains and complicate timely access to specialized reagents.
Asia-Pacific is anticipated to be a growing region in the Messenger Ribonucleic Acid (mRNA) Capping Enzyme market due to increased research activities and biotechnological advancements. For instance, in April 2025, according to the Mercator Institute for China Studies (org), the National Medical Products Administration (NMPA) of China had approved a total of 76 new drugs. This marked a 53% increase in the number of new medicines, with 85% of those having been invented by the companies from China. In the first six months of 2025, the number of vaccinations administered to protect people from novel coronavirus disease was 85 million. One-third of all the multi-regional clinical trials conducted globally were taking place in the Asia-Pacific region. The major pharmaceutical companies spent $3.15 billion in Chinese molecules. This growth is further supported by expanding biotechnology investments and mRNA research capabilities across the region.
Messenger Ribonucleic Acid (mRNA) Capping Enzyme Market- Competitive Landscape:
The competitive landscape of the Messenger Ribonucleic Acid (mRNA) Capping Enzyme market is evolving as key players such as TriLink Biotechnologies, Thermo Fisher Scientific, New England Biolabs, Jena Bioscience, and Aldevron produce next-generation cap analogs used during co-transcription. These analogs guarantee the maximum stability and translation efficiency. In February 2025, TriLink BioTechnologies entered into the non-exclusive license and supply agreement with Aldevron, giving access to the company’s mRNA capping technology—CleanCap®. This collaboration between the two firms looks like it will be highly significant for the future advancement of the mRNA capping technology.
Recent Developments:
- In May 2025, TriLink BioTechnologies signed a memorandum of understanding with the International Vaccine Institute for collaborating in the development of mRNA vaccines through knowledge exchange and joint scientific initiatives using mRNA technology.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Takara Bio Inc.
- Aldevron
- New England Biolabs Inc.
- CellScript Inc.
- Yeasen Biotechnology Co. Ltd.
- Novoprotein Scientific Inc.
- TriLink Biotechnologies LLC
- Jena Bioscience GmbH
- Vazyme Biotech Co. Ltd.
- Enzynomics Inc.
- Creative Enzymes
- Canvax Biotech SL
- APExBIO Technology LLC
- BOC Sciences
- KACTUS Biosystems
- Others
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes
- Cap 2 Capping Enzymes
- Cap 0 Capping Enzymes
- Cap 1 Capping Enzymes
- Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes
- (Guanine-N7)-Methyltransferase
- Guanylyltransferase
- RNA Triphosphatase
- Vaccinia Capping Enzyme (VCE)
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Diagnostics
- Research And Development
- Therapeutics
- Others
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Research Institutions
- Contract Manufacturing Organizations (CMOs)
- Pharmaceutical And Biotechnology Companies
- Others
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
TABLE OF CONTENT
1. mRNA Capping Enzyme Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.2. Competitive Insights
3. mRNA Capping Enzyme Key Market Trends
3.1. mRNA Capping Enzyme Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. mRNA Capping Enzyme Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. mRNA Capping Enzyme Market Opportunities
3.4. mRNA Capping Enzyme Market Future Trends
4. mRNA Capping Enzyme Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. mRNA Capping Enzyme Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. mRNA Capping Enzyme Market Landscape
6.1. mRNA Capping Enzyme Market Share Analysis, 2025
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. mRNA Capping Enzyme Market – By Product Type
7.1. Overview
7.1.1. Segment Share Analysis, By Product Type, 2025 & 2033 (%)
7.1.2. Natural mRNA Capping Enzymes
7.1.2.1. Cap 2 Capping Enzymes
7.1.2.2. Cap 0 Capping Enzymes
7.1.2.3. Cap 1 Capping Enzymes
7.1.3. Recombinant mRNA Capping Enzymes
7.1.3.1. (Guanine-N7)-Methyltransferase
7.1.3.2. Guanylyltransferase
7.1.3.3. RNA Triphosphatase
7.1.3.4. Vaccinia Capping Enzyme (VCE)
8. mRNA Capping Enzyme Market – By Application
8.1. Overview
8.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
8.1.2. Diagnostics
8.1.3. Research And Development
8.1.4. Therapeutics
8.1.5. Others
9. mRNA Capping Enzyme Market – By End User
9.1. Overview
9.1.1. Segment Share Analysis, By End User, 2025 & 2033 (%)
9.1.2. Research Institutions
9.1.3. Contract Manufacturing Organizations (CMOs)
9.1.4. Pharmaceutical And Biotechnology Companies
9.1.5. Others
10. mRNA Capping Enzyme Market – By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
10.2. North America
10.2.1. Overview
10.2.2. mRNA Capping Enzyme Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.5. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.6. North America Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. mRNA Capping Enzyme Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.16. Denmark
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.16.3. Denmark Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.16.4. Denmark Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.16.5. Denmark Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.3.17. Rest of Europe
10.3.17.1. Overview
10.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.3.17.4. Rest of the Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.3.17.5. Rest of the Europe Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. mRNA Capping Enzyme Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.15. Taiwan
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.15.3. Taiwan Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.15.4. Taiwan Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.15.5. Taiwan Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.16. Vietnam
10.4.16.1. Overview
10.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.16.3. Vietnam Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.16.4. Vietnam Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.16.5. Vietnam Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.4.17. Rest of APAC
10.4.17.1. Overview
10.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.4.17.3. Rest of APAC Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.4.17.4. Rest of APAC Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.4.17.5. Rest of APAC Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. mRNA Capping Enzyme Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. mRNA Capping Enzyme Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.13. Iran
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.13.3. Iran Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.13.4. Iran Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.13.5. Iran Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.14. Qatar
10.6.14.1. Overview
10.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.14.3. Qatar Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.14.4. Qatar Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.14.5. Qatar Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
10.6.15. Rest of MEA
10.6.15.1. Overview
10.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2020 - 2033, (US$ Million)
10.6.15.3. Rest of MEA Market Size and Forecast, By Product Type, 2020 - 2033 (US$ Million)
10.6.15.4. Rest of MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
10.6.15.5. Rest of MEA Market Size and Forecast, By End User, 2020 - 2033 (US$ Million)
11. Key Vendor Analysis- mRNA Capping Enzyme Industry
11.1. Competitive Benchmarking
11.1.1. Competitive Dashboard
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Roche AG
11.2.2. Thermo Fisher Scientific Inc.
11.2.3. Merck KGaA
11.2.4. Takara Bio Inc.
11.2.5. Aldevron
11.2.6. New England Biolabs Inc.
11.2.7. CellScript Inc.
11.2.8. Yeasen Biotechnology Co. Ltd.
11.2.9. Novoprotein Scientific Inc.
11.2.10. TriLink Biotechnologies LLC
11.2.11. Jena Bioscience GmbH
11.2.12. Vazyme Biotech Co. Ltd.
11.2.13. Enzynomics Inc.
11.2.14. Creative Enzymes
11.2.15. Canvax Biotech SL
11.2.16. APExBIO Technology LLC
11.2.17. BOC Sciences
11.2.18. KACTUS Biosystems
11.2.19. Others
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Roche AG
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Takara Bio Inc.
- Aldevron
- New England Biolabs Inc.
- CellScript Inc.
- Yeasen Biotechnology Co. Ltd.
- Novoprotein Scientific Inc.
- TriLink Biotechnologies LLC
- Jena Bioscience GmbH
- Vazyme Biotech Co. Ltd.
- Enzynomics Inc.
- Creative Enzymes
- Canvax Biotech SL
- APExBIO Technology LLC
- BOC Sciences
- KACTUS Biosystems
- Others
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2020 - 2033
- Natural Messenger Ribonucleic Acid (mRNA) Capping Enzymes
- Cap 2 Capping Enzymes
- Cap 0 Capping Enzymes
- Cap 1 Capping Enzymes
- Recombinant Messenger Ribonucleic Acid (mRNA) Capping Enzymes
- (Guanine-N7)-Methyltransferase
- Guanylyltransferase
- RNA Triphosphatase
- Vaccinia Capping Enzyme (VCE)
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033
- Diagnostics
- Research And Development
- Therapeutics
- Others
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY END USER- MARKET ANALYSIS, 2020 - 2033
- Research Institutions
- Contract Manufacturing Organizations (CMOs)
- Pharmaceutical And Biotechnology Companies
- Others
GLOBAL MESSENGER RIBONUCLEIC ACID (MRNA) CAPPING ENZYME MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Denmark
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Taiwan
- Vietnam
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Iran
- Qatar
- Rest of MEA
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Analystview Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
